Background Achilles tendon rupture is a common injury and the best treatment option remains uncertain between surgical and nonoperative methods. Biologic approaches using multipotent stem cells such as perivascular stem cells pose a possible treatment option, although there is currently a paucity of evidence regarding their clinical therapeutic use. Questions/purposes The purpose of this study was to determine whether injected perivascular stem cells (PSCs) would (1) improve histologic signs of tendon healing (such as percent area of collagen); and (2) improve biomechanical properties (peak load or stiffness) in a rat model of Achilles tendon transection. labeled with CM-diI to track cell viability and localization. At 3 weeks, the rats were euthanized, and investigators blinded to treatment group allocation evaluated tendon healing by peak load and stiffness using biomechanical testing and percent area of collagen using histologic analysis with picrosirius red staining. Results Histologic analysis showed a higher mean percent area collagen for pericytes (30%) and adventitial cells (28%) than hydrogel (21%) or saline (26%). However, a nonparametric statistical analysis yielded no statistical difference. Mechanical testing demonstrated that the pericyte group had a higher peak load than the saline group (41 6 7 N versus 26 6 9 N; mean difference 15 N; 95% confidence interval [CI], 4-27 N; p = 0.003) and a higher peak load than the hydrogel group (41 6 7 N versus 25 6 3 N; mean difference 16; 95% CI, 8-24 N; p = 0.001). The pericyte group demonstrated higher stiffness than the hydrogel group (36 6 12 N/mm versus 17 6 6 N/mm; mean difference 19 N/mm; 95% CI, 5-34 N/mm; p = 0.005). Conclusions Our results suggest that injection of PSCs improves mechanical but not the histologic properties of early Achilles tendon healing. Clinical Relevance This is a preliminary study that provides more insight into the use of adipose-derived PSCs as a percutaneous therapy in the setting of Achilles tendon rupture. Further experiments to characterize the function of these cells may serve as a pathway to development of minimally invasive intervention aimed at improving nonoperative management while avoiding the complications associated with surgical treatment down the line.
Abstract
Background Achilles tendon rupture is a common injury and the best treatment option remains uncertain between surgical and nonoperative methods. Biologic approaches using multipotent stem cells such as perivascular stem cells pose a possible treatment option, although there is currently a paucity of evidence regarding their clinical therapeutic use. Questions/purposes The purpose of this study was to determine whether injected perivascular stem cells (PSCs) would (1) improve histologic signs of tendon healing (such as percent area of collagen); and (2) improve biomechanical properties (peak load or stiffness) in a rat model of Achilles tendon transection. Methods Two subtypes of PSCs were derived from human adipose tissue: pericytes (CD146  + CD34   -CD45  -CD31   -)  and adventitial cells (CD146   -CD34 + CD45 -CD31 -). Thirtytwo athymic rats underwent right Achilles transection and were randomized to receive injection with saline (eight tendons), hydrogel (four tendons), pericytes in hydrogel (four tendons), or adventitial cells in hydrogel (eight tendons) 3 days postoperatively with the left serving as an uninjured control. Additionally, a subset of pericytes was
Introduction
Acute ruptures of the Achilles tendon are common and potentially disabling injuries. The annual incidence is reported to be 18 (range, 8.3-24) per 100,000 population [18, 47] . The pathophysiology of the injury is multifactorial but is primarily attributed to overuse combined with mechanical overload and physical susceptibility [28] . There is uncertainty regarding the most appropriate treatment of acute rupture of the Achilles tendon because studies have shown conflicting results regarding the comparative effectiveness of operative and nonoperative treatment [19, 21] . Although some studies report no difference in rerupture rates between surgical and nonsurgical management, others have concluded open repair of Achilles rupture reduces the risk of rerupture compared with conservative treatment [23, 43, 47] . Additionally, some recent studies have shown increased functional outcomes in athletes who underwent surgical repair, likely contributing to a preference for surgical treatment among the younger population [21, 26] .
Regenerative medicine practices involving replacing, engineering, or regenerating human cells, tissues, or organs to restore or establish normal function represent a potential alternative to both surgical and nonsurgical treatment modalities [31] . First described in the 1960s [17] and termed in 1991 mesenchymal stem cells (MSCs) have a well-recognized role in regenerative medicine applications [7] . However, clinical use of MSCs has many limitations. First, the in situ origin of MSCs remains unknown, although many clinically relevant sources such as periosteum, bone marrow, and adipose tissue have been identified [31, 36, 42, 52] . Second, MSCs require ex vivo expansion over several weeks before implantation and this process adversely affects the function of the cells and their therapeutic potency [27, 33] . Most importantly, MSCs are a heterogenous progenitor cell population, which is also reflected in their multilineage differentiation potential. Conversely, we have shown that perivascular cell subsets can be defined by a set of cell surface markers and enriched by cell sorting to yield relatively homogeneous subpopulations of perivascular progenitor cells: CD146+CD34-CD45-CD31-define pericytes, which are found around capillaries and microvessels, whereas CD146-CD34+CD45-CD31-define adventitial cells that are another type of perivascular stem cells (PSCs) found within the adventitia of larger vessels [4, 9-11, 22, 49] . As a result, there has been growing interest in the potential therapeutic application of PSCs, which have been established as mesodermal precursors within perivascular regions of all vascularized tissues [5, 13, 30, 46] . The ability of adipose tissue-derived pericytes to contribute to tissue regeneration was demonstrated in diabetic retinopathy, in which injected pericytes prevented capillary loss [29] . Additionally, multiple studies demonstrate the contribution of adipose tissue-derived pericytes to bone [25, 44, 51] and cartilage healing [3, 50] as well as to reduction of muscle loss in chronically injured mouse muscle [16] . Although the regenerative potential of pericytes is well documented, the regenerative potential of adventitial cells is still under investigation. To our knowledge, PSCs have not been evaluated in the setting of Achilles tendon injuries.
We therefore sought to determine whether injected PSCs would (1) improve histologic signs of tendon healing (such as percent area of collagen); and (2) improve biomechanical properties (peak failure load and stiffness) in a rat model of Achilles tendon transection. We hypothesized that the strength of cell-injected tendons, measured as peak failure load and stiffness, would be higher than saline and hydrogel-injected tendons. We further hypothesized that increased collagen deposition would occur at the injury site for the PSC groups.
Materials and Methods

Study Design and Surgery
Male athymic, T-cell-deficient nude rats at 10 weeks of age (n = 32, CRL316, Crl: NIK-Foxn1 rnu ; Charles River Laboratories International, Malvern, PA, USA) were used for all experiments. Athymic rats were chosen for this study to avoid immunologic responses to human PSCs being injected as well as their robust Achilles anatomy of the hind limbs [37] . Rats were housed under specific pathogen-free conditions with a 12-hour light/dark cycle, fed irradiated standard chow, and provided water ad libitum in the Animal Barrier Facility of the University of California, Los Angeles. All experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of California, Los Angeles.
All animals underwent percutaneous Achilles tendon transection surgery using a sterile technique under general isoflurane anesthesia following previously described methods [15] . After anesthesia induction, the animals were given a single dose of buprenorphine (0.08 mL, 0.3 mg/mL), which was repeated at 12-hour intervals through the third day postsurgery. The right hind limb was prepped and draped in a sterile fashion. Using a Miltex number 11 blade (Plainsboro, NJ, USA), the right Achilles tendon was percutaneously transected in the transverse plane in the midsubstance of the tendon proximal to the tendon insertion in the calcaneus. The percutaneous incision did not require suture closure. As a result of the minimally invasive nature of the procedure, it was unclear at the time of surgery if the plantaris tendon was transected. A total of 32 animals underwent right hind limb Achilles transection and the left hind limb tendons were left uninjured as controls. Eight animals were used for histology and the remaining were used for biomechanical analysis. All 32 animals were available for analysis. There were no deaths, infections, or other complications that resulted in loss of animals.
Injections and Cell Culture
On postoperative day 3 after Achilles tendon transection, we randomized the rats to groups undergoing one of four injections consisting of 50 mL (1) saline; (2) hydrogel; (3) hydrogel seeded with adventitial cells; or (4) hydrogel seeded with pericyte cells (Fig. 1 ). In addition, one animal was injected with hydrogel seeded with pericyte cells labeled with CellTracker CM-DiI cell membrane dye (ThermoFisher Scientific, Eugene, OR, USA). A 3-day time point for cell injections was chosen to avoid buprenorphine injections on days 1 and 2 (required by the UCLA Division of Laboratory Medicine) becoming confounding variables. We used a commercially available collagenbased hydrogel scaffold as a vehicle for cell delivery to promote cell viability and localization to the tendon defect. The hydrogel scaffold was prepared with 85% type I collagen, 10% 10 x phosphate-buffered saline, 2% 1 M NaOH, and 3% distilled water. All reagents were obtained from Fisher Scientific (Eugene, OR, USA). Approximately 1 million cells were suspended in 50 mL hydrogel scaffold per injection for groups 3 and 4.
Perivascular stem cells were isolated from human white adipose tissue [40] . These tissues were obtained from cosmetic procedures and were deidentified of any patientspecific information before their use. UCLA Institutional Biosafety Committee approval was obtained originally in 2009 and renewed in 2012 (IBC#17.09.0-r) for the use of these cells/lipoaspirate. Pericytes and adventitial cells were harvested using previously described methods [40] . Briefly, lipoaspirate samples were obtained and the bloody tumescent fraction was removed from adipose tissue Fig. 1 This figure represents our experimental outline. On day 0, the right Achilles tendon of a rat was transected. On day 3, the animals were injected based on their experimental injection groups. On day 21, animals were euthanized and the right and left Achilles tendons were harvested for biomechanical testing and histologic analysis. 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA) and incubated for 7 minutes at room temperature. Using fluorescence-activated cell sorting (FACS), isolated PSCs were divided into two distinct populations: pericytes (CD146+, CD34-, CD45-, and CD31-) and adventitial cells (CD146-, CD34+, CD45-, and CD31-), as previously described [13] . The following commercial antibodies were used for FACS sorting: CD146-FITC (AbD-Serotec, Hercules, CA, USA), CD31-PE (BD Pharmingen, Franklin Lakes, NJ, USA), CD45-APC-H7 (BD Biosciences), and CD34-APC (BD Biosciences, Franklin Lakes, NJ, USA). These purified cells were expanded in vitro and cultured in EGM-2 medium (Lonza, Heidelberg, Germany). The medium was changed every 3 to 4 days. All injections were performed using passage-5 cells.
In all groups, a 20-gauge syringe was used to administer cells. Before injection, the animals were placed under general anesthesia with isoflurane. Injections were directed to the site of the tendon defect in the midsubstance proximal to the tendon insertion in the calcaneus.
Tendon Harvest
On postoperative day 21, the animals were euthanized according to the IACUC protocol. Transected tendons on the right and normal tendons on the left side were harvested for biomechanical and histologic analysis. Both limbs were amputated bilaterally from the knee. The plantaris tendon was located and carefully separated from the Achilles tendon given its separate insertion on the plantar aspect of the foot. The plantaris tendon was always carefully dissected at its distal insertion to ensure isolation of the Achilles tendon. The Achilles tendon was then harvested and the length of the Achilles tendon was maximized by transecting the tendon at its distal attachment and by transecting proximally in the muscle belly and bluntly cleaning the myotendinous junction with Kimwipes™ (Kimberly-Clark, Fullerton, CA, USA).
Histology
For histologic analysis, each Achilles tendon sample was fixed in 4% paraformaldehyde at 25°C for 48 hours and submitted to a core laboratory for sectioning in the coronal plane and mounting. Representative sections were also stained with hematoxylin and eosin and these slides were digitized by the core facility.
Paraffin-embedded slides were dewaxed with xylene and then rehydrated. Slides were stained for fibrillar types I and III collagen using the Picrosirius Red Stain Kit (Polysciences Inc, Warrington, PA, USA). Images were taken under polarized light with a DMLB Leica microscope (McBain Systems, Chatsworth, CA, USA). Image analysis was performed to quantify the area fraction of birefringence exclusively in the remodeled region of the transection site. Four images at x 20 magnification were analyzed per tendon with two per group. The percent area of birefringent pixels was determined by converting images to black and white, where the threshold was set to convert all birefringent pixels to black and all nonbirefringent pixels to white. The area fraction of black pixels was determined using ImageJ software (National Institutes of Health, Bethesda, MD, USA) and reported as mean 6 standard error per group. All histologic analyses were calculated in a blind fashion by two independent observers (SKD, CDE).
CM-DiI-labeled pericytes were injected into the defect site 3 days after tendon transection and subsequently imaged after euthanasia using a wide-field fluorescent microscope (Axio Imager; Zeiss, Cambridge, UK).
Biomechanical Evaluation
Biomechanical properties were assessed immediately after euthanasia by investigators blinded to the treatment group allocation. Biomechanical experiments were conducted on an Instron tensile machine (Model 5564; Instron, Norwood, MA, USA) with a 1-kN load cell. Each tendon was securely held by grip clamps designed for testing soft tissues and positioned such that the healing site was centered between the clamps (Fig. 2) . The biomechanical load protocol applied to each sample consisted of pretensioning the system to 2 N at a rate of 1 N/min followed by testing to failure at a strain rate of 1.0 mm/s. A preload of 2 N was chosen as a consistent start condition for each specimen without damaging the tissue. Once the preload was achieved, the sample was tested at a rate of 1 mm/s, which equates to a strain rate of approximately 20% elongation per second. This strain rate is appropriate for testing of soft tissues because both strength and stiffness are unaffected when soft tissues are tested at strain rates between 10% and 100% per second [6] . Tendon failure was defined as midsubstance tearing. The data were used to generate loaddisplacement curves. The peak and slope of the linear portion of the curve were used to determine failure load (N) and stiffness (N/mm), respectively, for each sample. After completing the protocol, each sample was examined for the location of mechanical failure within the tendon (Fig. 2) . Mechanical testing values are reported as mean 6 standard error of the mean with n = 4 for the hydrogel and adventitial cell groups, n = 8 for the saline group, and n = 7 for the pericyte group based on the cells that were yielded from lipoaspirate and culturing (one of the tendon samples injected with pericytes was mistakenly destroyed while loading onto the clamps and thus not used as part of the data analysis).
Statistical Analysis
Student's t-tests were used to evaluate differences between groups for load to failure and stiffness. For these outcomes, the mean value along with the 95% confidence interval (CI) (6 1.96 x standard error of mean) is reported. Differences between transected and nontransected groups were evaluated using a significance level of p < 0.050. A Bonferroni correction was made for multiple comparisons between transected groups with a significance level of p < 0.008. All statistical analyses were performed using STATA 13 (StataCorp LP, College Station, TX, USA). With the small number (two) of histologic samples, a Kruskal-Wallis H nonparametric statistical analysis was performed using SPSS (released 2017, IBM SPSS Statistics for Windows, Version 25.0; IBM Corp, Armonk, NY, USA).
Results
Histology
Treatment with saline, hydrogel, pericytes, or adventitial cells did not result in any differences among the groups in terms of percent collagen with the numbers available. The mean percent area of birefringent pixels in the area of transection for saline, hydrogel, and pericytes adventitial cell groups is 26 6 5, 21 6 4, 28 6 4, and 30 6 6, respectively (Fig. 2) . A Kruskal-Wallis H test with 3 degrees of freedom yielded a p value of 0.198. In comparison to nontransected tendon (Fig. 3A) , hematoxylin and eosin staining demonstrated a full-thickness defect at the site of transection on all sampled operated Achilles tendons. This site was grossly thicker than the adjacent regions and nontransected tendons (Fig. 3C) . Under polarized light, positive birefringent staining was observed in all groups, signifying the presence of aligned collagen fibers (Fig. 3D) . Labeled pericytes, injected 3 days after transection, were localized to the region surrounding the site of transection (Fig. 4) .
Biomechanical Analysis
We found that transected tendon injected with pericyteloaded hydrogel had a higher load to failure than hydrogel and saline controls and was stiffer than saline control. These improvements in biomechanical strength did not reach the load to failure or stiffness of nontransected tendon. All tested samples failed at the midsubstance of the tendon. The nontransected group demonstrated higher load to failure than each of the transection groups injected, including hydrogel (62 6 6 N versus 41 6 7 N; mean difference 21; 95% CI, 13-29; p < 0.01), saline (62 6 6 N versus 26 6 9 N; mean difference 36; 95% CI, 32-46; p < 0.01), adventitial cells (62 6 6 N versus 31 6 8 N; mean difference 31; 95% CI, 20-42; p < 0.01), and pericytes (62 6 6 N versus 41 6 7 N; mean difference 21; 95% CI, 13-30; p < 0.01). The transected pericyte group had a higher peak load than the transected saline group (41 6 7 N versus 26 6 9 N; mean difference 15; 95% CI, 4-27; p = 0.003) and a higher peak load than the transected hydrogel differences in stiffness among transected groups injected with hydrogel, saline, adventitial cells, or pericytes (Fig. 6 ).
Discussion
Achilles tendon ruptures are common and serious orthopaedic injuries; however, the most appropriate treatment remains uncertain. Perivascular stem cells are mesodermal precursors of MSCs and represent a potential subset of stem cells in regenerative medicine [3, 25, 44, 50, 51] . Although these cells have been studied in the therapeutic regeneration of cardiac muscle and skeletal muscle, no prior study has explored the regenerative potential of pericytes or adventitial cells after Achilles tendon injury [8, [12] [13] [14] 32] . Previous studies investigating the regenerative potential of stem cells in the treatment of Achilles tendon rupture have demonstrated promising mechanical and histologic evidence of improved healing but have largely focused on the therapeutic potential of MSCs rather than PSCs [1, 2, 20, 34, 35, 41, 48] . We therefore assessed the utility of PSCs in an Achilles transection rodent model. Treatment with saline, hydrogel, pericytes, or adventitial cells did not result in any differences among the groups in terms of percent collagen, but tendon injected with pericyte-loaded hydrogel had higher load to failure than hydrogel and saline controls and was stiffer than saline control.
There are limitations of this study to consider. First, this study only investigated the effect of injected PSCs at a single time point of 3 weeks postinjury making it unclear whether prolonged healing would have additional effects for each of the injection groups. Future studies will include additional time points of both injection and tendon harvest to elucidate the timing of healing in this model and potentially optimize therapeutic treatments. Our use of young athymic rats to inject human PSCs makes clinical translatability unclear and thus future studies in bigger, more mature animal models using allogenic and autologous PSCs are needed to determine if these results will eventually be applicable to humans. The current study does not address the cellular mechanisms accounting for healing. Future experiments will investigate mRNA expression at healing time points to examine these specific mechanisms. The Achilles tendon transection model utilized in this study may not precisely reflect the degenerative model of Achilles tendon rupture observed clinically [39, 45] . This transection model was designed to be percutaneous and minimally invasive; as such, we were unable to determine whether the plantaris tendon, which runs along with the Achilles tendon, was also transected with each surgery. However, we confirmed separation of the Achilles tendon from the plantaris tendon before biomechanical testing for each dissection. Even in cases in which separation was difficult as a result of increased fibrosis from healing, we were able to locate the plantaris as a result of its separate distal attachment on the plantar aspect of the foot and carefully work distal to proximal. Alternative rat models that may simulate degenerative changes more accurately include treadmill-induced injury, dry needling, and collagenase injection [24, 38] . It is important to note that we did not use standard tensile testing, because we did not retain the calcaneal insertion of the Achilles tendon for clamping. To try to compensate for this, we made sure that every reported Achilles tendon tore midsubstance with tensile stress. We did not measure the cross-sectional areas of the Achilles tendons and thus were unable to calculate Young's modulus and true tensile strength, but rather are only able to report ultimate tensile load to failure for each tendon. This is an important limitation and we look to address this by measuring tensile strength in future experiments. As discussed in the Introduction, when compared with MSCs, PSCs could possibly be superior in musculoskeletal regenerative therapy; thus, using MSCs as controls is something we did not address in this study but can be done moving forward with future experiments. Lastly, being a preliminary study, we only used 24 animals for biomechanical testing and eight animals for histologic analysis. Although our results suggest that injected pericytes may increase the biomechanical strength (load to failure and stiffness) of ruptured Achilles tendon, it is not clear from the present data in a murine model that these increases are of clinical importance. As for histology, although our statistical analysis revealed no difference, we understand that our power is low and look to increase the number of animals as well as make an effort to further characterize the collagen in future experiments.
Using a rat model of Achilles tendon rupture without surgical repair, our study demonstrated that although histologic analysis of area fraction of collagen did not reveal a difference among the groups, adipose-derived human PSCs improved the mechanical healing properties 3 weeks after transection. Additionally, there were no major differences in stiffness observed in the adventitial group compared with the hydrogel or saline controls. The PSC groups did not attain comparable failure load or stiffness compared with nontransected controls; however, this was not expected at 3 weeks after injury without surgical repair. We do not exclude the possibility that hydrogels with different composition may enhance the healing of injured Achilles tendon. However, we demonstrate here that the kind of hydrogel that was used in this study was not sufficient to increase Achilles tendon healing when injected alone. From the mechanical testing data, it is evident that the pericyte injection group was the best in terms of enhancing the tensile failure load at 21 days postinjury. However, it is possible that this effect is transient, meaning that with prolonged healing time, other groups like hydrogel and adventitial would catch up with the healing results of the pericyte group. Perivascular stem cells present a possible future option for patients with musculoskeletal injuries. Our preliminary study showed that injection of PSCs can improve healing of the Achilles tendon, specifically with peak load failure and stiffness. Future studies with higher statistical power as well as larger animal models are needed to elucidate further clinical translatability of these cells. Furthermore, there is a fundamental need for further studies exploring the biologic pathways and clinical safety of PSCs because this is a relatively new field.
